Trial intelligence / Profile preview

Remimazolam vs Propofol for Sedation in ICU Patients

NCT04790734Phase 2Completed

Start
May 2021
Primary completion
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of remimazolam in critical illness. Started May 2021; status: completed.

02

Drugs

remimazolam
03

Conditions

critical illness

Beyond the preview

Go deeper on NCT04790734.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04790734.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call